A tour of recent patent applications addressing antibacterial resistance
- 1 August 2002
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 12 (8), 1159-1172
- https://doi.org/10.1517/13543776.12.8.1159
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of Resistant Mycoplasma Infection in Immunocompromised Patients with a New Pleuromutilin AntibioticJournal of Infection, 2001
- The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosomeMolecular Microbiology, 2001
- Once-Daily Dosing in Dogs Optimizes Daptomycin SafetyAntimicrobial Agents and Chemotherapy, 2000
- Antibiotic resistance: a current perspectiveBritish Journal of Clinical Pharmacology, 1999
- The Enoyl‐[Acyl‐Carrier‐Protein] Reductase (FabI) of Escherichia coli, which Catalyzes a Key Regulatory Step in Fatty Acid Biosynthesis, Accepts NADH and NADPH as Cofactors and is Inhibited by Palmitoyl‐CoAEuropean Journal of Biochemistry, 1996
- Regulation of Fatty Acid Elongation and Initiation by Acyl-Acyl Carrier Protein in Escherichia coliJournal of Biological Chemistry, 1996
- Hygromycin A: preparation of aminocyclitol analogs defining the minimum functionality required for biological activityBioorganic & Medicinal Chemistry Letters, 1992
- Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogsAntimicrobial Agents and Chemotherapy, 1981
- Hygromycin A, a Novel Inhibitor of Ribosomal PeptidyltransferaseEuropean Journal of Biochemistry, 1980
- New pleuromutilin derivatives with enhanced antimicrobial activity. I. Synthesis.The Journal of Antibiotics, 1976